Meniscus Tear
0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
ArthrexCA - Santa Barbara
2 programsNanoscopic partial meniscectomyN/A1 trial
SoftStitch™N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
ArthrexSoftStitch™
ArthrexNanoscopic partial meniscectomy
Ferring PharmaceuticalsEuflexxa
Clinical Trials (3)
Total enrollment: 34 patients across 3 trials
SoftStitch™ for All-Inside Meniscal Repair: Comparative Analysis of Patient Reported Outcome Measures
Start: Jul 2023Est. completion: Oct 2024
N/AUnknown
Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy
Start: Dec 2022Est. completion: Dec 2024
N/ARecruiting
Post-op Treatment With Hyaluronic Acid Injections
Start: Sep 2010Est. completion: Apr 201434 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 34 patients
2 companies competing in this space